# Catheter Ablation Therapy for Persistent Atrial Fibrillation

> **NCT02892162** · NA · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 214 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Additional LAAW linear ablation

## Key facts

- **NCT ID:** NCT02892162
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2017-07
- **Final completion:** 2019-07
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892162, "Catheter Ablation Therapy for Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02892162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*